In Vivo Gene Editing, Powered by AI

[tradelikepro]

Gene editing has traditionally been limited to ex vivo approaches, modifying cells outside the body before reintroducing them. GenEditBio is pioneering the next wave: precise, in-body (in vivo) delivery using engineered protein delivery vehicles (ePDVs).

AI powers the process, analyzing thousands of nanoparticles to predict which delivery vehicles can safely target specific tissues — the eye, liver, or nervous system — without triggering immune responses. Each lab experiment feeds data back into the model, improving accuracy and scalability.

This approach could make one-time gene therapies off-the-shelf and globally accessible, lowering costs and enabling treatments for rare disorders that were previously untouchable. AI isn’t just helping biotech work faster — it’s redefining what’s possible in medicine.

[madtrader]

ePDVs targeting tissues without immune responses… wild how precise this is getting